Boehringer Extends Collaboration With Ablynx for Alzheimer’s Disease

Published on Thursday 21 August 2008 - 19:34

Summary :
Ablynx … announced that the Alzheimer’s disease collaboration with Boehringer Ingelheim was proceeding well and therefore the research funding has been extended for another year.
Read more

Information source

FDAnews Drug Daily Bulletin

http://www.fdanews.com/

Website description
Each day you'll receive targeted FDA regulatory, legislative and business news briefs in the pharmaceutical and biologics industries. Plus, you'll get a snapshot of international news relevant to...

Articles published on this website : 0 / 7 days - 1 / 30 days

Alzheimer s Drugs Also Treat Behavioral, Psych Problems Merck Drug Fails to Slow Alzheimer s Symptoms GlaxoSmithKline in $550 Million Deal to Develop Alzheimer 'De-Tangling' Alzheimer's Drug Shows Promise Blood Pressure Drug Reduces Risk of Alzheimer's by

Other articles published on other websites on the same day

Authorities Search For Missing Man With Alzheimer's http://www.newsnet5.com/ Kim Stagliano: Why is Ohio Retarded but Connecticut Isn't? http://www.huffingtonpost.com/ Alzheimer’s research seeks volunteers http://www.onalaskalife.com/ Blueberries Are Little Miracles http://www.stopagingnow.com/ Oshawa caregiver stole $34,000 from war vet: police http://network.nationalpost.com/ The Alzheimer Spouse Website Teams up with Caregiver Cruises and Author Teena Cahill http://www.webwire.com/ How A Vice-Presidential Bid Is A Political Dead End [Politics] http://gawker.com/ Nasdaq warns Oncothyreon; ATS buys majority share of Ganymed; http://www.fiercebiotech.com/ Alzheimer testing in Texas http://www.kvue.com/ Hospice lecture this morning at Westminster http://www.bradenton.com/